stella
beta
Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07) — Stella
Recruiting
Back to TNBC - Triple-Negative Breast Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
China
The First Affiliated Hospital of Anhui Medical University, Hefei
Zhongshan Hospital, Fudan University, Shanghai
View full record on ClinicalTrials.gov